Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 22:24 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
NCT02072096 · Eli Lilly and Company · PHASE4 · terminated · last registry update 2019-10-09 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “The trial was terminated per protocol because of lack of feasibility.” | – | Registry record, Eli Lilly and Company |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against KCNJ11 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2020-07-22Phase 3 first posted: Cairo University, Topical cetirizine + Placebo (NCT04481412)
- 2020-07-07Results posted on the registry: M.H.H. Kramer, Dapagliflozin 10mg QD + Gliclazide 30mg QD (NCT02682563)
- 2020-05-14Results posted on the registry: University College Dublin, Sitagliptin + Gliclazide (NCT01991197)
- 2020-04-08Results posted on the registry: Mayo Clinic, Minoxidil Foam (NCT03488108)
- 2020-03-19Results posted on the registry: Daiichi Sankyo, Tolbutamide + Midazolam (NCT03291288)
- 2020-03-16Results posted on the registry: Farid Masoud, Topical Herbal Solution + Topical Minoxidil 5% (NCT03753113)
- 2019-09-12Phase 3 first posted: Soleno Therapeutics, Inc., DCCR (NCT04086810)
- 2019-09-06Results posted on the registry: Kissei Pharmaceutical Co., Ltd., KAD-1229 + Placebo (NCT02154347)
- 2019-07-26Results posted on the registry: Hospices Civils de Lyon, Minoxidil + Placebo (NCT00876200)
- 2019-07-16Results posted on the registry: Merck KGaA, Darmstadt, Germany, Metformin/Gliclazide Fixed Combination + Metformin (NCT03467945)
- 2019-07-08Results posted on the registry: Merck KGaA, Darmstadt, Germany, Metformin/Gliclazide Fixed Combination (NCT03467971)
- 2018-11-26Phase 3 first posted: Farid Masoud, Topical Herbal Solution + Topical Minoxidil 5% (NCT03753113)
- 2018-10-22Phase 3 first posted: Soleno Therapeutics, Inc., DCCR + DCCR (NCT03714373)
- 2018-10-19Results posted on the registry: Eli Lilly and Company, Tolbutamide + Tasisulam (NCT01185548)
- 2018-10-19Also stopped (terminated): Eli Lilly and Company, Tolbutamide + Tasisulam (NCT01185548)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision